Study: CPAP may benefit those with prediabetes
PHILADELPHIA –Prediabetic patients with obstructive sleep apnea (OSA) saw significant improvement in their glucose levels after CPAP treatment, according to a small clinical trial. The study, conducted by researchers at McGill University and the American Thoracic Society (ATS), found that glucose levels declined to favorable levels for patients treated with CPAP devices, while those levels increased in a control group, according to a press release from the ATS. “We found that optimal treatment of sleep apnea with positive airway pressure for two weeks led to significant improvements in glucose levels,” stated Shumita Pamidi, MD, of McGill University, who led the study. Pamidi added that this may signal “an improvement in insulin sensitivity” among those who receive CPAP treatment, according to the release.